Zolgensma, which became the most expensive medicine in the world last May, will be offered to one hundred babies under two years of age, who will be chosen by lot…
Read More
Zolgensma, which became the most expensive medicine in the world last May, will be offered to one hundred babies under two years of age, who will be chosen by lot…
Read More
On Tuesday, the Swiss stock exchange, with the other trading venues, set out on a clear recovery from the heavy levies of the past week. After a cautious opening, the…
Read More
GSK, Geçen hafta Pfizer‘ın (PFE.N) tüketici sağlık hizmetlerini satın almak için yarıştan ayrıldı ve ABD’li ilaç üreticisinin 20 milyar dolar getirisinin olacağını umduğunu açıkladı. Böylece firma, 2015’te kurulan, Novartis ürünleri…
Read MorePage 1 of 1